With cases of antibiotic-resistant MRSA multiplying and fear of the superbug rising, Cepheid was perfectly positioned when it came out with a rapid genetic screening test. Sales have soared as Cepheid ...

Cepheid's performance in the first quarter was driven by robust growth in clinical product sales resulting from test utilization in the emerging HAI test market for Xpert MRSA, continued adoption of ...

On Monday, the U.S. Food and Drug Administration approved a new test for methicillin-resistant Staphylococcus aureus detection manufactured by Cepheid. Cepheid’s Xpert MRSA NxG test delivers ...

July 3, 2010 — A test to detect methicillin-resistant Staphylococcus aureus (MRSA) and S aureus (SA) has been recalled by the manufacturer based on an increasing number of complaints about false ...

CepheidCPHD recently launched its Xpert MRSA NxG assay in the commercial markets overseas, after the test won the CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices.

In Mexico, Cepheid has received registration from the Secretary of Health for its GeneXpert System and Xpert (TM) MRSA, Xpert GBS and Xpert EV tests. The products will be distributed exclusively ...

Co announces it received clearance from the FDA to market its Xpert M.R.S.A test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus. "Currently ...

But you wannabe day-traders are too late. The stock of Sunnyvale-based Cepheid has already more than doubled in the past six months. Cepheid makes gene-based testing systems for whatever nasty germ is ...

Danaher announced Tuesday that it has entered an agreement to acquire molecular diagnostics player Cepheid for approximately $4 billion. Cepheid specializes in molecular diagnostics and markets tests ...

These include fast, accurate, and easy to use tests for SARS-CoV-2, the virus causing COVID-19, Flu, MRSA, tuberculosis, and other HAI, sexual health, and oncology diseases. Each test is designed for ...